MANHATTAN, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a Manhattan-headquartered investment bank and broker-dealer, today announced that it acted as the exclusive placement agent in connection with iSpecimen Inc.'s (NASDAQ:ISPC) private placement, raising approximately $5.5 million in gross proceeds before fees and expenses.

The transaction reflects continued capital markets interest in differentiated healthcare technology platforms that support medical research and discovery. iSpecimen operates an online global marketplace connecting scientists with healthcare specimen providers, enabling more efficient access to biospecimens critical for clinical and translational research.

Pursuant to the securities purchase agreement, iSpecimen will issue 6,875 shares of newly designated Series C Convertible Preferred Stock at a purchase price of $800 per share. Each share has a stated value of $1,000 and is ...